Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
Purpose
This phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer. Duloxetine increases the amount of certain chemicals in the brain that help relieve depression and pain. Giving duloxetine in patients undergoing treatment with oxaliplatin for colorectal cancer may help prevent peripheral neuropathy.
Conditions
- Stage II Colorectal Cancer AJCC v8
- Stage III Colorectal Cancer AJCC v8
Eligibility
- Eligible Ages
- Over 25 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Criteria
- Stage II-III colorectal cancer patients scheduled to receive oxaliplatin 510 mg/m^2
(cumulative dose) over 12 weeks as a component of adjuvant leucovorin calcium (calcium
folinate), 5-fluorouracil and oxaliplatin (FOLFOX) treatment, in which patients are
scheduled to receive oxaliplatin 85 mg/m^2 every 2 weeks for 12 weeks (i.e., 6
cycles), or adjuvant capecitabine and oxaliplatin (CAPOX) treatment, in which patients
are scheduled to receive oxaliplatin 135 mg/m^2 every 3 weeks for 12 weeks (i.e., 4
cycles)
- No prior neurotoxic chemotherapy
- No pre-existing clinical or pre-clinical peripheral neuropathy from any cause.
- No history of seizure disorder,
- No history of narrow-angle glaucoma.
- No symptoms of or history of schizophrenia, bipolar disease, suicidal thoughts and/or
a major depression.
- No serious eating disorder such as bulimia or anorexia.
- No known diagnosis of ethanol (ETOH) addiction/dependence within the past 10 years.
- Concomitant medications:
- No concomitant use of other adjuvant pharmacologic interventions (e.g.,
gabapentin, pregabalin, venlafaxine) with known or hypothesized efficacy for
peripheral neuropathy. Must be discontinued at least 7 days prior to start of
protocol treatment
- No anticipated or concurrent use of any antidepressant or serotonin-altering
agent known to interact with duloxetine, due to concern regarding cumulative
toxicity and potential drug interactions.
- Use of a monoamine oxidase inhibitor (MAOI) or other antidepressants must be
discontinued at least 14 days prior to start of protocol treatment.
- No concomitant treatment with strong CYP1A2 and CYP2D6 inhibitors.
- Chronic concomitant treatment with drugs that are extensively metabolized by
CYP2D6 and that have a narrow therapeutic index, including certain
antidepressants, phenothiazines, and Type 1C antiarrhythmics should be approached
with caution. Concomitant administration of duloxetine and thioridazine should be
avoided.
- No use of warfarin or heparin products.
- Not pregnant and not nursing, because this study involves an investigational agent
whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn
are unknown. Therefore, for women of childbearing potential, a negative pregnancy test
done =< 7 days prior to registration is required
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- In order to complete the mandatory patient-completed measure, patients must be able to
speak and read English
- Calculated creatinine clearance > 30 mL/min
- Aspartate aminotransferases (AST)/serum glutamic-oxaloacetic transaminase (SGOT) =< 3
x upper limit of normal (ULN)
Study Design
- Phase
- Phase 2/Phase 3
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Sequential Assignment
- Primary Purpose
- Supportive Care
- Masking
- Double (Participant, Investigator)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Phase II, Arm I (duloxetine hydrochloride, placebo) |
Patients in Phase II receive duloxetine hydrochloride 30 mg (1 duloxetine capsule) orally (PO) once daily (QD) during week 1, duloxetine hydrochloride 30 mg (1 duloxetine capsule) PO QD and placebo (1 placebo capsule) PO QD during weeks 2-16, followed by duloxetine hydrochloride 30 mg (1 duloxetine capsule) PO QD during week 17 in the absence of unacceptable toxicity. |
|
Experimental Phase II, Arm II (duloxetine hydrochloride) |
Patients in Phase II receive duloxetine hydrochloride 30 mg (1 duloxetine capsule) orally (PO) once daily (QD) during week 1, duloxetine hydrochloride 60 mg (2 duloxetine capsules) PO QD during weeks 2-16, followed by duloxetine hydrochloride 30 mg (1 duloxetine capsule) PO QD during week 17 in the absence of unacceptable toxicity. |
|
Placebo Comparator Phase II, Arm III (placebo) |
Patients in Phase II receive placebo (1 placebo capsule) orally (PO) once daily (QD) during week 1, placebo (2 placebo capsules) PO QD weeks 2-16, followed by placebo (1 placebo capsule) PO QD during week 17 in the absence of unacceptable toxicity. |
|
Experimental Phase III, Arm I (duloxetine hydrochloride) |
Patients in Phase III receive most promising dose of duloxetine hydrochloride from Phase II PO QD in the absence of unacceptable toxicity. |
|
Placebo Comparator Phase III, Arm II (placebo) |
Patients in Phase III receive placebo PO QD in the absence of unacceptable toxicity. |
|
Recruiting Locations
Birmingham, Alabama 35233
Mobile, Alabama 36688
Anchorage, Alaska 98508
Anchorage, Alaska 99504
Anchorage, Alaska 99508
Anchorage, Alaska 99508
Anchorage, Alaska 99508
Anchorage, Alaska 99508
Anchorage, Alaska 99508
Anchorage, Alaska 99508
Kingman, Arizona 86401
Phoenix, Arizona 85004
Fort Smith, Arkansas 72903
Site Public Contact
800-378-9373
Little Rock, Arkansas 72205
Little Rock, Arkansas 72205
Little Rock, Arkansas 72205
Site Public Contact
501-686-8274
Arroyo Grande, California 93420
Arroyo Grande, California 93420
Burbank, California 91505
Carmichael, California 95608
Carmichael, California 95608
Duarte, California 91010
Dublin, California 94568
Site Public Contact
925-875-1677
Elk Grove, California 95758
Emeryville, California 94608
Site Public Contact
510-835-9900
Emeryville, California 94608
Site Public Contact
510-629-6682
Fremont, California 94538
Site Public Contact
510-745-6433
Lancaster, California 93534
Martinez, California 94553-3156
Site Public Contact
925-957-5400
Merced, California 95340
Napa, California 94558
Site Public Contact
707-521-3830
Oakland, California 94609
Rancho Mirage, California 92270
Site Public Contact
760-834-3798
Rocklin, California 95765
Sacramento, California 95816
San Francisco, California 94110
San Luis Obispo, California 93401
Santa Maria, California 93444
Santa Rosa, California 95403
Site Public Contact
707-521-3830
South Pasadena, California 91030
Upland, California 91786
Walnut Creek, California 94597
Woodland, California 95695
Colorado Springs, Colorado 80907
Colorado Springs, Colorado 80907
Colorado Springs, Colorado 80909
Site Public Contact
719-365-2406
Colorado Springs, Colorado 80920
Site Public Contact
719-364-6700
Colorado Springs, Colorado 80923
Denver, Colorado 80205
Denver, Colorado 80206
Denver, Colorado 80218
Durango, Colorado 81301
Durango, Colorado 81301
Fort Collins, Colorado 80524
Site Public Contact
970-297-6150
Fort Collins, Colorado 80528
Golden, Colorado 80401
Golden, Colorado 80401
Grand Junction, Colorado 81501
Greeley, Colorado 80631
Greeley, Colorado 80631
Lafayette, Colorado 80026
Lakewood, Colorado 80228
Lone Tree, Colorado 80124
Longmont, Colorado 80501
Loveland, Colorado 80538
Site Public Contact
970-203-7083
Loveland, Colorado 80539
Pueblo, Colorado 81004
Thornton, Colorado 80260
Wheat Ridge, Colorado 80033
Hartford, Connecticut 06102
Site Public Contact
860-545-5363
Meriden, Connecticut 06451
Site Public Contact
866-662-5678
New Britain, Connecticut 06050
Site Public Contact
860-224-5660
Stamford, Connecticut 06904
Site Public Contact
203-323-8944
Frankford, Delaware 19945
Lewes, Delaware 19958
Newark, Delaware 19713
Newark, Delaware 19713
Newark, Delaware 19718
Rehoboth Beach, Delaware 19971
Wilmington, Delaware 19801
Washington, District of Columbia 20002
Site Public Contact
301-548-5743
Washington, District of Columbia 20010
Site Public Contact
202-877-8839
Altamonte Springs, Florida 32701
Site Public Contact
407-303-2200
Celebration, Florida 34747
Site Public Contact
407-303-4120
Clearwater, Florida 33756
Site Public Contact
855-314-8646
Fort Lauderdale, Florida 33308
Site Public Contact
954-267-7748
Kissimmee, Florida 34744
Site Public Contact
407-846-4343
Orlando, Florida 32803
Site Public Contact
407-897-3499
Orlando, Florida 32803
Orlando, Florida 32822
Site Public Contact
407-303-8110
Plant City, Florida 33563
Safety Harbor, Florida 34695
Saint Petersburg, Florida 33705
Tampa, Florida 33607
Winter Park, Florida 32792
Site Public Contact
407-646-7000
Albany, Georgia 31701
Augusta, Georgia 30901
Site Public Contact
706-821-2944
Augusta, Georgia 30909
Site Public Contact
706-736-1830
Boise, Idaho 83706
Boise, Idaho 83712
Caldwell, Idaho 83605
Coeur d'Alene, Idaho 83814
Emmett, Idaho 83617
Fruitland, Idaho 83619
Meridian, Idaho 83642
Meridian, Idaho 83642
Nampa, Idaho 83686
Nampa, Idaho 83687
Post Falls, Idaho 83854
Sandpoint, Idaho 83864
Twin Falls, Idaho 83301
Alton, Illinois 62002
Site Public Contact
618-463-5623
Aurora, Illinois 60504
Bloomington, Illinois 61704
Burr Ridge, Illinois 60527
Site Public Contact
708-216-9000
Canton, Illinois 61520
Carbondale, Illinois 62902
Carterville, Illinois 62918
Carthage, Illinois 62321
Centralia, Illinois 62801
Centralia, Illinois 62801
Chicago, Illinois 60611
Chicago, Illinois 60612
Site Public Contact
312-469-4304
Chicago, Illinois 60612
Site Public Contact
312-864-5204
Danville, Illinois 61832
Decatur, Illinois 62526
Decatur, Illinois 62526
DeKalb, Illinois 60115
Dixon, Illinois 61021
Site Public Contact
815-285-7800
Effingham, Illinois 62401
Effingham, Illinois 62401
Eureka, Illinois 61530
Galesburg, Illinois 61401
Galesburg, Illinois 61401
Site Public Contact
309-344-2831
Geneva, Illinois 60134
Harvey, Illinois 60426
Homer Glen, Illinois 60491
Site Public Contact
708-216-9000
Kewanee, Illinois 61443
Macomb, Illinois 61455
Mattoon, Illinois 61938
Maywood, Illinois 60153
Site Public Contact
708-226-4357
Melrose Park, Illinois 60160
Site Public Contact
708-450-4554
Moline, Illinois 61265
Site Public Contact
309-779-2000
Mount Vernon, Illinois 62864
Site Public Contact
618-242-4600
O'Fallon, Illinois 62269
O'Fallon, Illinois 62269
Ottawa, Illinois 61350
Pekin, Illinois 61554
Peoria, Illinois 61615
Peoria, Illinois 61636
Peru, Illinois 61354
Peru, Illinois 61354
Site Public Contact
815-664-4141
Princeton, Illinois 61356
River Forest, Illinois 60305
Rockford, Illinois 61108
Site Public Contact
815-227-2633
Shiloh, Illinois 62269
Springfield, Illinois 62702
Site Public Contact
217-545-7929
Springfield, Illinois 62702
Site Public Contact
800-444-7541
Springfield, Illinois 62781
Urbana, Illinois 61801
Urbana, Illinois 61801
Warrenville, Illinois 60555
Washington, Illinois 61571
Yorkville, Illinois 60560
Crown Point, Indiana 46307
Site Public Contact
219-310-2550
Dyer, Indiana 46311
Site Public Contact
219-924-8178
Hobart, Indiana 46342
Site Public Contact
219-947-1795
Hobart, Indiana 46342
Indianapolis, Indiana 46312
Munster, Indiana 46321
Site Public Contact
219-836-3349
Munster, Indiana 46321
Richmond, Indiana 47374
Valparaiso, Indiana 46383
Ames, Iowa 50010
Site Public Contact
515-956-4132
Ames, Iowa 50010
Ankeny, Iowa 50023
Site Public Contact
515-282-2921
Boone, Iowa 50036
Site Public Contact
515-956-4132
Carroll, Iowa 51401
Cedar Rapids, Iowa 52402
Site Public Contact
319-297-2900
Cedar Rapids, Iowa 52403
Site Public Contact
319-365-4673
Cedar Rapids, Iowa 52403
Site Public Contact
319-363-2690
Clive, Iowa 50325
Site Public Contact
515-241-3305
Clive, Iowa 50325
Council Bluffs, Iowa 51503
Council Bluffs, Iowa 51503
Site Public Contact
712-322-4136
Council Bluffs, Iowa 51503
Creston, Iowa 50801
Des Moines, Iowa 50309
Site Public Contact
515-241-6727
Des Moines, Iowa 50309
Site Public Contact
515-241-3305
Des Moines, Iowa 50314
Site Public Contact
515-282-2200
Des Moines, Iowa 50314
Des Moines, Iowa 50314
Site Public Contact
515-241-3305
Des Moines, Iowa 50316
Site Public Contact
515-241-8704
Fort Dodge, Iowa 50501
Site Public Contact
515-956-4132
Fort Dodge, Iowa 50501
Site Public Contact
515-574-8302
Jefferson, Iowa 50129
Site Public Contact
515-956-4132
Marshalltown, Iowa 50158
Site Public Contact
515-956-4132
West Des Moines, Iowa 50266-7700
Site Public Contact
515-343-1000
West Des Moines, Iowa 50266
Chanute, Kansas 66720
Dodge City, Kansas 67801
El Dorado, Kansas 67042
Garden City, Kansas 67846
Great Bend, Kansas 67530
Hays, Kansas 67601
Site Public Contact
785-623-5774
Independence, Kansas 67301
Kingman, Kansas 67068
Lawrence, Kansas 66044
Liberal, Kansas 67905
Manhattan, Kansas 66502
McPherson, Kansas 67460
Newton, Kansas 67114
Olathe, Kansas 66061
Parsons, Kansas 67357
Pittsburg, Kansas 66762
Pittsburg, Kansas 66762
Pratt, Kansas 67124
Salina, Kansas 67401
Salina, Kansas 67401
Topeka, Kansas 66606
Site Public Contact
785-295-8000
Wellington, Kansas 67152
Wichita, Kansas 67208
Wichita, Kansas 67214
Wichita, Kansas 67214
Winfield, Kansas 67156
Bardstown, Kentucky 40004
Corbin, Kentucky 40701
Lexington, Kentucky 40504
Lexington, Kentucky 40504
Lexington, Kentucky 40509
London, Kentucky 40741
Mount Sterling, Kentucky 40353
Baton Rouge, Louisiana 70805
Baton Rouge, Louisiana 70808
Site Public Contact
225-765-7659
Baton Rouge, Louisiana 70809
Baton Rouge, Louisiana 70809
Baton Rouge, Louisiana 70809
Baton Rouge, Louisiana 70816
Baton Rouge, Louisiana 70836
Covington, Louisiana 70433
Covington, Louisiana 70433
Houma, Louisiana 70360
Kenner, Louisiana 70065
New Orleans, Louisiana 70121
Augusta, Maine 04330
Site Public Contact
207-626-4855
Bangor, Maine 04401
Site Public Contact
207-973-4274
Belfast, Maine 04915
Site Public Contact
207-338-2500
Biddeford, Maine 04005
Brewer, Maine 04412
Site Public Contact
800-987-3005
Rockport, Maine 04856
Sanford, Maine 04073
South Portland, Maine 04106
Aberdeen, Maryland 21001
Baltimore, Maryland 21204
Site Public Contact
443-849-3706
Baltimore, Maryland 21237
Site Public Contact
443-777-7364
Baltimore, Maryland 21239
Baltimore, Maryland 21244
Site Public Contact
301-816-7218
Bel Air, Maryland 21014
Site Public Contact
443-643-3010
Easton, Maryland 21601
Elkton, Maryland 21921
Gaithersburg, Maryland 20879
Site Public Contact
301-816-7218
Kensington, Maryland 20895
Site Public Contact
301-816-7218
Largo, Maryland 20774
Site Public Contact
301-816-7446
Lutherville, Maryland 21093
Site Public Contact
410-847-3000
Boston, Massachusetts 02111
Plymouth, Massachusetts 02360
Ann Arbor, Michigan 48106
Battle Creek, Michigan 49017
Brighton, Michigan 48114
Brighton, Michigan 48114
Canton, Michigan 48188
Canton, Michigan 48188
Caro, Michigan 48723
Chelsea, Michigan 48118
Chelsea, Michigan 48118
Clarkston, Michigan 48346
Clarkston, Michigan 48346
Dearborn, Michigan 48124
Site Public Contact
248-551-7695
Detroit, Michigan 48236
East China Township, Michigan 48054
Farmington Hills, Michigan 48336
Site Public Contact
248-551-7695
Flint, Michigan 48503
Flint, Michigan 48503
Flint, Michigan 48503
Flint, Michigan 48503
Grand Rapids, Michigan 49503
Grand Rapids, Michigan 49503
Grand Rapids, Michigan 49503
Grosse Pointe Woods, Michigan 48236
Grosse Pointe Woods, Michigan 48236
Kalamazoo, Michigan 49007
Kalamazoo, Michigan 49007
Kalamazoo, Michigan 49009
Kalamazoo, Michigan 49048
Lansing, Michigan 48912
Livonia, Michigan 48154
Macomb, Michigan 48044
Marlette, Michigan 48453
Muskegon, Michigan 49444
Niles, Michigan 49120
Site Public Contact
616-391-1230
Norton Shores, Michigan 49444
Pontiac, Michigan 48341
Pontiac, Michigan 48341
Pontiac, Michigan 48341
Pontiac, Michigan 48341
Reed City, Michigan 49677
Royal Oak, Michigan 48067
Site Public Contact
248-551-7695
Royal Oak, Michigan 48073
Site Public Contact
248-551-7695
Royal Oak, Michigan 48073
Site Public Contact
248-551-7695
Royal Oak, Michigan 48073
Site Public Contact
248-551-7695
Royal Oak, Michigan 48073
Site Public Contact
248-551-7695
Royal Oak, Michigan 48073
Site Public Contact
248-551-7695
Saginaw, Michigan 48601
Saginaw, Michigan 48604
Saint Joseph, Michigan 49085
Saint Joseph, Michigan 49085
Sterling Heights, Michigan 48312
Sterling Heights, Michigan 48312
Site Public Contact
248-551-7695
Tawas City, Michigan 48764
Traverse City, Michigan 49684
Troy, Michigan 48084
Site Public Contact
248-551-7695
Troy, Michigan 48085
Site Public Contact
248-551-7695
Troy, Michigan 48098
Site Public Contact
248-551-7695
Warren, Michigan 48088
Warren, Michigan 48093
Warren, Michigan 48093
Warren, Michigan 48093
Warren, Michigan 48093
West Branch, Michigan 48661
Wyoming, Michigan 49519
Ypsilanti, Michigan 48106
Ypsilanti, Michigan 48197
Bemidji, Minnesota 56601
Burnsville, Minnesota 55337
Cambridge, Minnesota 55008
Coon Rapids, Minnesota 55433
Edina, Minnesota 55435
Mankato, Minnesota 56001
Site Public Contact
855-776-0015
Maple Grove, Minnesota 55369
Maplewood, Minnesota 55109
Maplewood, Minnesota 55109
Minneapolis, Minnesota 55407
Minneapolis, Minnesota 55415
Minneapolis, Minnesota 55417
Site Public Contact
612-467-2800
Minneapolis, Minnesota 55454
Monticello, Minnesota 55362
New Ulm, Minnesota 56073
Princeton, Minnesota 55371
Robbinsdale, Minnesota 55422
Rochester, Minnesota 55905
Site Public Contact
855-776-0015
Saint Cloud, Minnesota 56303
Saint Louis Park, Minnesota 55416
Saint Paul, Minnesota 55101
Saint Paul, Minnesota 55102
Shakopee, Minnesota 55379
Stillwater, Minnesota 55082
Thief River Falls, Minnesota 56701
Site Public Contact
605-312-3320
Waconia, Minnesota 55387
Willmar, Minnesota 56201
Woodbury, Minnesota 55125
Worthington, Minnesota 56187
Site Public Contact
605-312-3320
Wyoming, Minnesota 55092
Ballwin, Missouri 63011
Site Public Contact
314-251-7058
Bolivar, Missouri 65613
Branson, Missouri 65616
Site Public Contact
417-269-4520
Cape Girardeau, Missouri 63703
Cape Girardeau, Missouri 63703
Site Public Contact
573-651-5550
Creve Coeur, Missouri 63141
Farmington, Missouri 63640
Site Public Contact
314-996-5569
Jefferson City, Missouri 65109
Joplin, Missouri 64804
Joplin, Missouri 64804
Kansas City, Missouri 64108
Site Public Contact
816-404-4375
Kansas City, Missouri 64111
Lee's Summit, Missouri 64086
Osage Beach, Missouri 65065
Rolla, Missouri 65401
Rolla, Missouri 65401
Site Public Contact
573-458-6379
Saint Joseph, Missouri 64506
Saint Louis, Missouri 63109
Site Public Contact
314-353-1870
Saint Louis, Missouri 63110
Saint Louis, Missouri 63128
Saint Louis, Missouri 63129
Saint Louis, Missouri 63131
Site Public Contact
314-996-5569
Saint Louis, Missouri 63136
Saint Louis, Missouri 63141
Site Public Contact
314-251-7066
Saint Peters, Missouri 63376
Sainte Genevieve, Missouri 63670
Site Public Contact
314-996-5569
Springfield, Missouri 65804
Site Public Contact
417-269-4520
Springfield, Missouri 65807
Site Public Contact
417-269-4520
Sullivan, Missouri 63080
Site Public Contact
314-996-5569
Sunset Hills, Missouri 63127
Site Public Contact
314-996-5569
Washington, Missouri 63090
Site Public Contact
636-390-1600
Anaconda, Montana 59711
Billings, Montana 59101
Bozeman, Montana 59715
Great Falls, Montana 59405
Great Falls, Montana 59405
Kalispell, Montana 59901
Missoula, Montana 59802
Missoula, Montana 59804
Kearney, Nebraska 68847
Lincoln, Nebraska 68510
Lincoln, Nebraska 68516
Lincoln, Nebraska 68516
Omaha, Nebraska 68114
Site Public Contact
402-334-4773
Omaha, Nebraska 68114
Site Public Contact
402-354-5144
Omaha, Nebraska 68114
Omaha, Nebraska 68122
Omaha, Nebraska 68124
Omaha, Nebraska 68130
Omaha, Nebraska 68131
Papillion, Nebraska 68046
Carson City, Nevada 89703
Henderson, Nevada 89052
Henderson, Nevada 89052
Henderson, Nevada 89052
Henderson, Nevada 89052
Henderson, Nevada 89074
Henderson, Nevada 89074
Henderson, Nevada 89074
Henderson, Nevada 89074
Las Vegas, Nevada 89102
Las Vegas, Nevada 89102
Las Vegas, Nevada 89103
Las Vegas, Nevada 89106
Las Vegas, Nevada 89106
Las Vegas, Nevada 89109
Las Vegas, Nevada 89109
Las Vegas, Nevada 89113
Las Vegas, Nevada 89113
Las Vegas, Nevada 89119
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89135
Las Vegas, Nevada 89144
Las Vegas, Nevada 89144
Las Vegas, Nevada 89144
Las Vegas, Nevada 89148
Las Vegas, Nevada 89148
Las Vegas, Nevada 89148
Las Vegas, Nevada 89169
Las Vegas, Nevada 89169
Pahrump, Nevada 89048
Reno, Nevada 89502
Reno, Nevada 89503
Reno, Nevada 89509
Mullica Hill, New Jersey 08062
Teaneck, New Jersey 07666
Site Public Contact
201-833-6312
Albuquerque, New Mexico 87102
Auburn, New York 13021
Site Public Contact
315-472-7504
Bronx, New York 10461
Bronx, New York 10461
Bronx, New York 10467
Cooperstown, New York 13326
East Syracuse, New York 13057
Site Public Contact
315-472-7504
Glens Falls, New York 12801
Site Public Contact
518-926-6700
Syracuse, New York 13215
Site Public Contact
315-472-7504
Asheville, North Carolina 28803
Clyde, North Carolina 28721
Hendersonville, North Carolina 28792
Washington, North Carolina 27889
Weaverville, North Carolina 28787
Bismarck, North Dakota 58501
Fargo, North Dakota 58103
Site Public Contact
701-234-6161
Fargo, North Dakota 58103
Site Public Contact
605-312-3320
Fargo, North Dakota 58104
Site Public Contact
800-437-4010
Fargo, North Dakota 58122
Fargo, North Dakota 58122
Grand Forks, North Dakota 58201
Site Public Contact
701-780-6520
Akron, Ohio 44307
Alliance, Ohio 44601
Site Public Contact
330-363-1250
Beavercreek, Ohio 45431
Boardman, Ohio 44512
Canton, Ohio 44710
Centerville, Ohio 45459
Cincinnati, Ohio 45219
Cincinnati, Ohio 45220
Cincinnati, Ohio 45236
Cincinnati, Ohio 45242
Cincinnati, Ohio 45247
Cincinnati, Ohio 45255
Cleveland, Ohio 44111
Dayton, Ohio 45415
Findlay, Ohio 45840
Findlay, Ohio 45840
Findlay, Ohio 45840
Franklin, Ohio 45005
Greenville, Ohio 45331
Greenville, Ohio 45331
Independence, Ohio 44131
Kettering, Ohio 45409
Kettering, Ohio 45429
Mansfield, Ohio 44906
Mayfield Heights, Ohio 44124
Sandusky, Ohio 44870
Steubenville, Ohio 43952
Site Public Contact
888-874-7000
Strongsville, Ohio 44136
Sylvania, Ohio 43560
Toledo, Ohio 43606
Troy, Ohio 45373
Warrensville Heights, Ohio 44122
Warren, Ohio 44484
West Chester, Ohio 45069
Wooster, Ohio 44691
Wright-Patterson Air Force Base, Ohio 45433
Youngstown, Ohio 44501
Lawton, Oklahoma 73505
Site Public Contact
877-231-4440
Oklahoma City, Oklahoma 73104
Oklahoma City, Oklahoma 73109
Oklahoma City, Oklahoma 73120
Site Public Contact
405-752-3402
Oklahoma City, Oklahoma 73142
Site Public Contact
405-773-6613
Baker City, Oregon 97814
Bend, Oregon 97701
Clackamas, Oregon 97015
Clackamas, Oregon 97015
Coos Bay, Oregon 97420
Newberg, Oregon 97132
Ontario, Oregon 97914
Oregon City, Oregon 97045
Portland, Oregon 97213
Portland, Oregon 97225
Redmond, Oregon 97756
Site Public Contact
541-706-2909
Allentown, Pennsylvania 18103
Altoona, Pennsylvania 16601
Beaver, Pennsylvania 15009
Bethlehem, Pennsylvania 18017
Butler, Pennsylvania 16001
Carlisle, Pennsylvania 17015
Chadds Ford, Pennsylvania 19317
Coudersport, Pennsylvania 16915
Danville, Pennsylvania 17822
East Stroudsburg, Pennsylvania 18301
Erie, Pennsylvania 16505
Farrell, Pennsylvania 16121
Greensburg, Pennsylvania 15601
Site Public Contact
724-838-1900
Greenville, Pennsylvania 16125
Harrisburg, Pennsylvania 17101
Harrisburg, Pennsylvania 17109
Hazleton, Pennsylvania 18201
Hazleton, Pennsylvania 18201
Indiana, Pennsylvania 15701
Johnstown, Pennsylvania 15901
Site Public Contact
814-534-4724
Lewisburg, Pennsylvania 17837
McKeesport, Pennsylvania 15132
Site Public Contact
412-647-8073
Mechanicsburg, Pennsylvania 17050
Monroeville, Pennsylvania 15146
Moon, Pennsylvania 15108
Mount Pleasant, Pennsylvania 15666
N. Huntingdon, Pennsylvania 15642
Natrona Heights, Pennsylvania 15065
Site Public Contact
724-230-3030
New Castle, Pennsylvania 16105
Pittsburgh, Pennsylvania 15215
Site Public Contact
412-784-4900
Pittsburgh, Pennsylvania 15219
Site Public Contact
800-533-8762
Pittsburgh, Pennsylvania 15232
Site Public Contact
412-647-8073
Pittsburgh, Pennsylvania 15237
Site Public Contact
412-367-6454
Pittsburgh, Pennsylvania 15243
Site Public Contact
412-502-3920
Pottsville, Pennsylvania 17901
Sayre, Pennsylvania 18840
Site Public Contact
800-836-0388
Scranton, Pennsylvania 18510
Selinsgrove, Pennsylvania 17870
Seneca, Pennsylvania 16346
Site Public Contact
814-676-7900
Uniontown, Pennsylvania 15401
Washington, Pennsylvania 15301
West Mifflin, Pennsylvania 15122
Site Public Contact
412-653-8100
Wilkes-Barre, Pennsylvania 18711
Williamsport, Pennsylvania 17754
Willow Grove, Pennsylvania 19090
York, Pennsylvania 17408
Site Public Contact
717-724-6760
Beaufort, South Carolina 29902
Boiling Springs, South Carolina 29316
Site Public Contact
864-241-6251
Charleston, South Carolina 29425
Easley, South Carolina 29640
Georgetown, South Carolina 29440
Greenville, South Carolina 29605
Site Public Contact
864-241-6251
Greenville, South Carolina 29605
Site Public Contact
864-241-6251
Greenville, South Carolina 29615
Site Public Contact
864-241-6251
Greenwood, South Carolina 29646
Greer, South Carolina 29650
Site Public Contact
864-241-6251
Seneca, South Carolina 29672
Site Public Contact
864-241-6251
Sioux Falls, South Dakota 57104
Sioux Falls, South Dakota 57117-5134
Bristol, Tennessee 37620
Cookeville, Tennessee 38501
Site Public Contact
931-783-2714
Kingsport, Tennessee 37660
Kingsport, Tennessee 37660
Austin, Texas 78701
Site Public Contact
512-324-7991
Austin, Texas 78712
Berlin, Vermont 05602
Site Public Contact
802-225-5400
Burlington, Vermont 05401
Burlington, Vermont 05405
Bristol, Virginia 24201
Burke, Virginia 22015
Fairfax, Virginia 22031
Fairfax, Virginia 22033
Falls Church, Virginia 22042
Martinsville, Virginia 24115
McLean, Virginia 22102
Site Public Contact
240-632-4284
Mechanicsville, Virginia 23116
Midlothian, Virginia 23113
Midlothian, Virginia 23114
Norton, Virginia 24273
Richmond, Virginia 23223
Richmond, Virginia 23226
Richmond, Virginia 23229
Richmond, Virginia 23230
Richmond, Virginia 23235
Richmond, Virginia 23298
South Hill, Virginia 23970
Winchester, Virginia 22601
Woodbridge, Virginia 22192
Aberdeen, Washington 98520
Bellingham, Washington 98225
Site Public Contact
360-788-8223
Bremerton, Washington 98310
Bremerton, Washington 98310
Centralia, Washington 98531
Edmonds, Washington 98026
Everett, Washington 98201
Issaquah, Washington 98029
Kennewick, Washington 99336
Lacey, Washington 98503
Longview, Washington 98632
Renton, Washington 98055
Seattle, Washington 98107
Seattle, Washington 98122-5711
Seattle, Washington 98122
Sedro-Woolley, Washington 98284
Shelton, Washington 98584
Vancouver, Washington 98664
Walla Walla, Washington 99362
Yakima, Washington 98902
Yelm, Washington 98597
Bridgeport, West Virginia 26330
Martinsburg, West Virginia 25401
Morgantown, West Virginia 26506
Parkersburg, West Virginia 26101
Princeton, West Virginia 24740
Site Public Contact
304-487-7515
Wheeling, West Virginia 26003
Site Public Contact
304-243-6442
Appleton, Wisconsin 54911
Appleton, Wisconsin 54915
Brookfield, Wisconsin 53045
Chilton, Wisconsin 53014
Chippewa Falls, Wisconsin 54729
Eau Claire, Wisconsin 54701
Eau Claire, Wisconsin 54701
Site Public Contact
855-776-0015
Fond Du Lac, Wisconsin 54935
Site Public Contact
800-494-2927
Franklin, Wisconsin 53132
Franklin, Wisconsin 53132
Green Bay, Wisconsin 54301
Green Bay, Wisconsin 54303
Ladysmith, Wisconsin 54848
Marshfield, Wisconsin 54449
Mequon, Wisconsin 53097
Milwaukee, Wisconsin 53211
Milwaukee, Wisconsin 53215
Minocqua, Wisconsin 54548
Mukwonago, Wisconsin 53149
New Richmond, Wisconsin 54017
Oconomowoc, Wisconsin 53066
Site Public Contact
262-928-7878
Oconto Falls, Wisconsin 54154
Oshkosh, Wisconsin 54904
Racine, Wisconsin 53405
Rice Lake, Wisconsin 54868
Stevens Point, Wisconsin 54482
Sturgeon Bay, Wisconsin 54235-1495
Waukesha, Wisconsin 53188
Site Public Contact
262-928-7632
Waukesha, Wisconsin 53188
Wausau, Wisconsin 54401
Wauwatosa, Wisconsin 53226
Weston, Wisconsin 54476
Wisconsin Rapids, Wisconsin 54494
Cody, Wyoming 82414
Sheridan, Wyoming 82801
More Details
- NCT ID
- NCT04137107
- Status
- Recruiting
- Sponsor
- Alliance for Clinical Trials in Oncology
Detailed Description
The primary and secondary objectives of the study: PRIMARY OBJECTIVES: I. To determine the dosage of duloxetine hydrochloride (duloxetine) (30 mg or 60 mg daily) that appears most promising in preventing oxaliplatin-induced peripheral neuropathy (OIPN). (Phase II) II. To demonstrate that the most promising dosage of duloxetine identified in the Phase II component is more effective than placebo at preventing OIPN sensory symptoms. (Phase III) III. To demonstrate that the most promising dosage of duloxetine identified in the Phase II component is more effective than placebo at preventing oxaliplatin-induced chronic neuropathic pain. (Phase III) SECONDARY OBJECTIVES: I. To characterize toxicity in each arm, including duloxetine side effects of nausea, dry mouth, dizziness, somnolence, fatigue, and insomnia using Common Terminology Criteria for Adverse Events (CTCAE) version (v) 5.0. (Phase II) II. To compare the serially measured OIPN total sensory neuropathy scores calculated from the six individual Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20 (QLQ-CIPN20) questions that quantify numbness, tingling, and pain in the fingers (or hands) and toes (or feet), measured on day 1 of each cycle of oxaliplatin treatment and at 1 month post-oxaliplatin treatment between the most promising dosage of duloxetine identified in the Phase II component and placebo. (Phase III) III. To compare the serially measured Brief Pain Inventory Short Form (BPI-SF) patient-reported on the average pain scores, measured on day 1 of each cycle of oxaliplatin treatment and at 1 month post-oxaliplatin treatment between the most promising dosage of duloxetine identified in the Phase II component and placebo. IV. To characterize toxicity in each arm, including duloxetine side effects of nausea, dry mouth, dizziness, somnolence, fatigue, and insomnia using the CTCAE v 5.0. (Phase III) OUTLINE: PHASE II: Patients are randomized to 1 of 3 arms. ARM I: Patients in Phase II receive duloxetine hydrochloride 30 mg (1 duloxetine capsule) orally (PO) once daily (QD) during week 1, duloxetine hydrochloride 30 mg (1 duloxetine capsule) PO QD and placebo (1 placebo capsule) PO QD during weeks 2-16, followed by duloxetine hydrochloride 30 mg (1 duloxetine capsule) PO QD during week 17 in the absence of unacceptable toxicity. ARM II: Patients in Phase II receive duloxetine hydrochloride 30 mg (1 duloxetine capsule) orally (PO) once daily (QD) during week 1, duloxetine hydrochloride 60 mg (2 duloxetine capsules) PO QD during weeks 2-16, followed by duloxetine hydrochloride 30 mg (1 duloxetine capsule) PO QD during week 17 in the absence of unacceptable toxicity. ARM III: Patients in Phase II receive placebo (1 placebo capsule) orally (PO) once daily (QD) during week 1, placebo (2 placebo capsules) PO QD weeks 2-16, followed by placebo (1 placebo capsule) PO QD during week 17 in the absence of unacceptable toxicity. PHASE III: Patients are randomized to 1 of 2 arms. ARM I: Patients in Phase III receive most promising dose of duloxetine hydrochloride from Phase II PO QD in the absence of unacceptable toxicity. ARM II: Patients in Phase III receive placebo PO QD in the absence of unacceptable toxicity. NOTE: Patients in all arms receive standard of care oxaliplatin during weeks 1-12. After completion of study, patients are followed up at 30 days and at 3, 6, 12, and 18 months after last oxaliplatin treatment.